Project Details
| Status | Active |
|---|---|
| Effective start/end date | 1/08/24 → 31/07/29 |
Clinical Trial Phase
- Phase I
A Phase 1/1b Open-Label Dose-Escalation and Dose-Optimization Study of Bcl-2 Inhibitor BGB-21447 in Patients With Mature B-Cell Malignancies
- Opat, Stephen (Primary Chief Investigator (PCI))
Project: Research